Skip to main content
Premium Trial:

Request an Annual Quote

Good Advice

The Guardian's Adam Smith wrote last week that scientists must be engaged in the political process if they want their concerns to be heard. In a commentary in Nature, University of Cambridge researcher Robert Doubleday and the University of Sussex's James Wilsdon write that the UK has a pretty good model for making science a political priority and that this model "is increasingly seen as a template elsewhere." The UK's government has a chief scientific advisor — currently the post is filled by John Beddington, whose five-year term is ending in December — who oversees 22 departmental chief scientific advisors. "Equivalent posts have been created in New Zealand and at the European Commission in the past few years, and are proposed in Japan and at the United Nations," Doubleday and Wilsdon write. The US has an equivalent in the post of the presidential scientific advisor, but whereas this person serves the White House, the British CSA serves all departments of government.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.